A Pilot Study Examining the Safety and Tolerability of Valacyclovir in Veterans With Hepatitis C Virus/Herpes Simplex Virus Type 2 Coinfection

Valacyclovir 1 g twice daily showed no evidence of hepatotoxicity in U.S. veterans with hepatitis C. A modest reduction in serum levels of ALT and plasma levels of HCV RNA was observed.